Protalex's Reverse Merger Round

Protalex raised a round of funding on October 27, 2004. Investors include Public.

Protalex ( is a biotechnology company engaged in the development of a new class of immunomodulatory drugs for treatment of rheumatoid arthritis and other autoimmune diseases. The comp…

Articles about Protalex's Reverse Merger Round: